NEK5 and neoplasm: Bioinformatics tools and databases, such as the cancer cell line encyclopedia (CCLE) and tumor immune estimation resource (TIMER), suggest that NEK5 is differentially expressed in this cancer and could serve as a potential biomarker for prognosis and therapeutic targeting [140,141,142].